All sessions are listed in Eastern Time. 

Pre-conference Session

  • Date:
  • Time: -
  • Track: Education
  • CME/CE: 3
  • Q & A: None

Additional fee session
Sponsored by the Association of Directors of Geriatric Academic Programs (ADGAP) 

Amyloid Antibodies for Alzheimer’s and Your Academic Geriatric Program
This session will summarize the evidence for amyloid antibodies and discuss the role of the academic geriatric program from a clinical, educational, and research perspective. Learning Objectives: (1) describe the current state of the science on Amyloid Antibodies; (2) utilize approaches learned to support your programs; and (3) identify the roles of Geriatricians in the research on Amyloid Antibodies.

TimeAgenda Item
2:30 PM Welcome
Eric Widera, MD
2:35 PMA Summary of the Evidence for Amyloid Antibodies
Jason Karlawish, MD 
Eric Widera, MD
2:55 PMWhat AGS is Doing: Policy Efforts & Curriculum
Michael Harper, MD
Mark Supiano, MD
3:10 PMDevelopment of Geriatrics Teams in Prescribing and Managing MABs
Heather Whitson, MD, MHS (moderator)
Hamid R. Okhravi, MD
Daniel Parker, MD
Catherine Sarkisian, MD, MSHS 
3:35 PMQ & A
3:50 PMPreparing Geriatrics Fellows for a New Era in Diagnosing and Treating Alzheimer’s Disease
Esther Oh, MD (moderator)
Halima Amjad, MD, PhD, MPH
Jo Cleveland, MD
Angela Hanson, MD
4:15 PMQ & A
4:30 PMBreak
4:40 PMIntegrating Alzheimer’s Disease and Related Dementias into your Academic Program's Research Portfolio
Sanjay Asthana, MD (moderator)
Sharon Brangman, MD
Cynthia Carlsson, MD, MS 
 Joshua Chodosh, MD, MSHS
5:05 PMQ & A
5:20 PMClosing Remarks
Eric Widera, MD